Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 24579062)

1.

Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study.

Still CD, Wood GC, Benotti P, Petrick AT, Gabrielsen J, Strodel WE, Ibele A, Seiler J, Irving BA, Celaya MP, Blackstone R, Gerhard GS, Argyropoulos G.

Lancet Diabetes Endocrinol. 2014 Jan;2(1):38-45.

2.

Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.

Blackstone R, Bunt JC, Cortés MC, Sugerman HJ.

Surg Obes Relat Dis. 2012 Sep-Oct;8(5):548-55. doi: 10.1016/j.soard.2012.05.005. Epub 2012 May 18.

PMID:
22721581
3.

Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.

Aarts EO, Janssen J, Janssen IM, Berends FJ, Telting D, de Boer H.

Obes Surg. 2013 Jul;23(7):867-73. doi: 10.1007/s11695-013-0872-8.

PMID:
23475775
4.

Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.

Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, DeMaria EJ.

Surg Obes Relat Dis. 2009 May-Jun;5(3):305-9. doi: 10.1016/j.soard.2009.02.007. Epub 2009 Feb 26.

PMID:
19460674
5.

Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: a retrospective cohort analysis.

Wood GC, Gerhard GS, Benotti P, Petrick AT, Gabrielsen JD, Strodel WE, Ibele A, Rolston DD, Still CD, Argyropoulos G.

Ann Surg. 2015 Jan;261(1):125-8. doi: 10.1097/SLA.0000000000000588.

PMID:
24646545
6.
7.

Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients.

Boza C, Muñoz R, Salinas J, Gamboa C, Klaassen J, Escalona A, Pérez G, Ibañez L, Guzmán S.

Obes Surg. 2011 Sep;21(9):1330-6. doi: 10.1007/s11695-011-0463-5.

PMID:
21744283
8.

[Efficacy of modified Roux-en-Y gastric bypass in the treatment of non-obese type 2 diabetes mellitus:one year follow-up].

Chen YF, Yang F, Yang YL, Wu N, Zheng ZG, Li XL, Yang B, Wang L, Chen Y, Lian HL, Song B, Xue YJ, Cai HW, Dou KF, Chen Y.

Zhonghua Wai Ke Za Zhi. 2012 Oct;50(10):879-82. Chinese.

PMID:
23302455
9.

Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques.

Robert M, Ferrand-Gaillard C, Disse E, Espalieu P, Simon C, Laville M, Gouillat C, Thivolet C.

Obes Surg. 2013 Jun;23(6):770-5. doi: 10.1007/s11695-013-0868-4.

PMID:
23355293
10.

Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients?

Torquati A, Lutfi R, Abumrad N, Richards WO.

J Gastrointest Surg. 2005 Nov;9(8):1112-6; discussion 1117-8.

PMID:
16269382
11.

Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.

Park JY, Kim YJ.

Obes Surg. 2015 Jul 24. [Epub ahead of print]

PMID:
26205218
12.

Efficacy of the Roux-en-Y gastric bypass compared to medically managed controls in meeting the American Diabetes Association composite end point goals for management of type 2 diabetes mellitus.

Leslie DB, Dorman RB, Serrot FJ, Swan TW, Kellogg TA, Torres-Villalobos G, Buchwald H, Slusarek BM, Sampson BK, Bantle JP, Ikramuddin S.

Obes Surg. 2012 Mar;22(3):367-74. doi: 10.1007/s11695-011-0494-y.

PMID:
21918925
13.

Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient.

Dorman RB, Serrot FJ, Miller CJ, Slusarek BM, Sampson BK, Buchwald H, Leslie DB, Bantle JP, Ikramuddin S.

Ann Surg. 2012 Feb;255(2):287-93. doi: 10.1097/SLA.0b013e318232b033.

PMID:
21975321
14.

Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy.

Dunn JP, Abumrad NN, Breitman I, Marks-Shulman PA, Flynn CR, Jabbour K, Feurer ID, Tamboli RA.

Diabetes Care. 2012 Jan;35(1):137-42. doi: 10.2337/dc11-1383. Epub 2011 Oct 31.

15.

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP.

JAMA. 2013 Jun 5;309(21):2240-9. doi: 10.1001/jama.2013.5835.

16.

Long-term outcomes in gastric bypass patients with and without type 2 diabetes--Waitemata District Health Board experience.

Lam AH, Kim DD, Cutfield R, Walker C, Booth M.

N Z Med J. 2013 Nov 22;126(1386):21-30.

PMID:
24316990
17.

Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2.

Proczko-Markuszewska M, Stefaniak T, Kaska Ł, Sledziński Z.

Pol Przegl Chir. 2011 Feb;83(2):81-6. doi: 10.2478/v10035-011-0013-9.

PMID:
22166285
18.

Statistical models to predict type 2 diabetes remission after bariatric surgery.

Ramos-Levi AM, Matia P, Cabrerizo L, Barabash A, Sanchez-Pernaute A, Calle-Pascual AL, Torres AJ, Rubio MA.

J Diabetes. 2014 Sep;6(5):472-7. doi: 10.1111/1753-0407.12127. Epub 2014 Feb 26.

PMID:
24433454
19.

Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults.

Arterburn D, Bogart A, Coleman KJ, Haneuse S, Selby JV, Sherwood NE, Sidney S, Theis MK, Campos GM, McCulloch D, O' Connor PJ.

Obes Res Clin Pract. 2013 Jul-Aug;7(4):e258-68. doi: 10.1016/j.orcp.2012.08.196.

PMID:
24306153
20.

Effect of laparoscopic Roux-en-Y gastric bypass surgery on hemoglobin A1c levels in diabetic patients: a matched-cohort analysis.

Mumme DE, Mathiason MA, Kallies KJ, Kothari SN.

Surg Obes Relat Dis. 2009 Jan-Feb;5(1):4-10. doi: 10.1016/j.soard.2008.11.009. Epub 2008 Nov 25.

PMID:
19161932
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk